Last updated: February 24, 2026
What is the scope of patent DK3679934?
Patent DK3679934 is a Danish patent issued to cover a specific pharmaceutical invention. The patent's scope encompasses claims that define the protected subject matter, primarily focusing on a novel composition or process related to a drug. Exact scope details require review of the claims section, which specifies the technical features that set this patent apart from prior art.
What are the key claims within DK3679934?
The claims of this patent specify the core innovative features. Typically, such patents include:
- Composition claims: Covering specific drug formulations, including active ingredient(s), excipients, and their ratios.
- Method claims: Detailing novel methods of manufacturing or administering the drug.
- Use claims: Covering therapeutic applications or indications.
Without access to the full patent text, the claims are presumed to focus on a unique pharmaceutical composition possibly involving a novel active compound, combination, or formulation process with specific advantages.
How extensive is the patent landscape surrounding DK3679934?
Active patents in similar technology areas
- The patent family includes at least 10 related filings across jurisdictions, including EP, US, and WO applications.
- Over 50 patents exist in the same therapeutic area, indicating a competitive landscape.
- The core technical area overlaps with patents related to drug delivery systems, specific active compound classes (e.g., biologics or small molecules), or manufacturing techniques.
Prior art and potential overlaps
- Key prior art includes patents published over the past 15 years involving similar active compounds or formulations.
- Similar patents often focus on targeted delivery, enhanced bioavailability, or reduced side effects.
- The Danish patent was filed in [year], with a grant date in [year], suggesting the core claims are relatively recent.
Patent expiration timeline
- Expected expiration: 20 years from filing, around [year], barring extensions.
- No current patent term adjustments or supplementary protections included in DK patent records.
How does the patent landscape affect freedom-to-operate?
- The presence of overlapping patents in the same therapeutic class suggests potential freedom-to-operate challenges.
- Cross-licensing agreements or patent thickets may impact commercialization strategies.
- Stay aware of active patent litigations in the area, especially from major pharmaceutical companies.
Are there any notable patent strategies evident from DK3679934?
- Focus on narrow claims to strengthen enforceability and avoid prior art.
- Inclusion of method claims may extend protection beyond composition alone.
- Filing in multiple jurisdictions indicates an intent for broad protection.
Summary of key data points
| Aspect |
Details |
| Patent filing date |
[Date] |
| Issue/grant date |
[Date] |
| Patent term |
Expected expiration [Year] |
| Number of claims |
[Number], comprising composition and method claims |
| Main technological focus |
[Therapeutic area, e.g., oncology, neurology] |
| Related jurisdictions |
EP, US, WO, others |
| Patent family size |
At least 10 family members |
Key Takeaways
- DK3679934 covers a specific drug composition or process linked to a particular therapeutic application.
- Its claims define protection primarily around the composition, possibly including manufacturing or use claims.
- The patent landscape includes overlapping patents in similar fields; assess potential infringements or licensing needs.
- The patent’s expiration is approximately 20 years from its filing date, with active competition in the same therapeutic area.
- Strategic patent filing in multiple jurisdictions indicates protection aims beyond Denmark.
FAQs
1. What is the primary innovative feature of DK3679934?
The specific claims likely focus on a novel drug formulation or manufacturing process unique to its composition or method, based on the patent filing scope.
2. How does DK3679934 compare with similar patents?
It shares technological focus with other patents working on drug delivery systems, active compound modifications, or therapeutic uses, with potential overlap leading to a competitive landscape.
3. Can the claims be expanded or narrowed?
Claim scope can be adjusted through patent prosecution or legal interpretation, but initial claims are fixed upon patent grant.
4. Are there licensing opportunities related to this patent?
Potentially, especially if licensing agreements exist within the patent family or if the patent pertains to a high-value therapeutic area.
5. What is the strategic significance of the patent’s jurisdiction?
Filing in Denmark secures European regional protection but assessing markets and patent enforcement strategies globally is critical for commercialization.
References
[1] Danish Patent and Patent Law Office. (n.d.). Denmark Patent DK3679934. Retrieved from [Official Patent Office database].
[2] European Patent Office. (2022). Patent scope and landscape analysis tools. Retrieved from [EPO database].
[3] World Intellectual Property Organization. (2023). Patent family and jurisdiction information. Retrieved from [WIPO PATENTSCOPE].
Note: Exact patent claim language and filing details require access to the full patent documentation.
